| 2024-03-11 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 7,345 0.0076% | $65.97 | $484,537 | +3.8% | |
| 2024-03-07 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 13,132 0.0134% | $66.15 | $868,698 | +1.83% | |
| 2024-02-26 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 7,907 0.0079% | $69.53 | $549,784 | -5.04% | |
| 2024-02-02 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 11,860 0.012% | $66.42 | $787,719 | +1.75% | |
| 2024-01-11 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 50,000 0.0513% | $66.83 | $3.34M | +0.5% | |
| 2023-03-13 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 7,344 0.0077% | $44.94 | $330,007 | +35.93% | |
| 2023-03-10 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 16,708 0.0172% | $43.10 | $720,086 | +38.64% | |
| 2023-02-24 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 7,906 0.0083% | $47.03 | $371,819 | +27.97% | |
| 2023-02-21 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 1,200 0.0013% | $48.76 | $58,508 | +29.6% | |
| 2023-02-21 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 11,139 0.0118% | $46.84 | $521,699 | +29.6% | |
| 2022-12-01 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 50,000 0.053% | $53.73 | $2.69M | +3.46% | |
| 2022-02-24 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 7,906 0.0083% | $51.98 | $410,933 | -2.17% | |
| 2022-02-22 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 11,139 0.0122% | $55.40 | $617,100 | -3.92% | |
| 2022-01-10 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 19,639 0.0211% | $40.77 | $800,774 | +29.07% | |
| 2021-12-21 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 176,863 0.2148% | $47.56 | $8.41M | +9.7% | |
| 2021-02-19 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 11,139 0.0137% | $39.24 | $437,133 | -4.23% | |
| 2021-01-11 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 19,638 0.0243% | $32.03 | $628,978 | +15.93% | |
| 2021-01-04 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 16,160 0.0197% | $31.30 | $505,834 | +16.63% | |
| 2020-11-17 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 79,425 0.0985% | $27.62 | $2.19M | +25.74% | |
| 2020-01-09 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP and General Counsel | 39,276 0.0621% | $26.16 | $1.03M | -9.06% |